登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 江苏四环生物股份有限公司（以下简称"公司"）于2025年6月4日召开了第十届董事会第十三次会议，审 议通过了《关于变更注册地址并修订〈公司章程〉的议案》（公告编号：临-2025-38号），上述议案已 经2025年第三次临时股东会审议通过（公告编号：临-2025-46号）。 近日，公司已完成了相关工商变更登记和章程备案手续，并取得了新的《营业执照》，公司变更后的注 册信息如下： 公司名称：江苏四环生物股份有限公司 统一社会信用代码：913202001381477183 类型：股份有限公司（上市） 法定代表人：邱为碧 注册资本：102,955.6222万人民币 成立日期：1992年5月18日 住所：江阴市滨江东路2号41楼05、06座 经营范围：大容量注射剂（含多层共挤膜输液袋）、小容量注射剂（含抗肿瘤药）、片剂（含抗肿瘤 药）、硬胶囊剂、糖浆剂、口服溶液剂、酒剂、原料药、中药提取、二类精神药品的制造；雪域骨宝 （胶囊、片剂）、博尔腾牌乃可菲胶囊、茵曼金牌硒化螺旋藻片 ...

Core Points - The company is Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd, established in 1993 and registered in Jilin Province, China [4][6][7] - The company aims to build a health industry chain and ecosystem, contributing to the modernization and internationalization of the national health industry while maximizing shareholder returns [9] - The registered capital of the company is RMB 966,494,707 [7] Chapter Summaries Chapter 1: General Principles - The company is established to protect the rights of shareholders, employees, and creditors, following the Company Law and Securities Law of the People's Republic of China [4] - The company has undergone several changes in its registration and licensing, including a name change to Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd in 2000 [6][7] Chapter 2: Business Objectives and Scope - The business objectives include serving human health and contributing to the health industry [9] - The business scope includes manufacturing various pharmaceutical forms, research and development of traditional Chinese medicine, and medical project investments [9] Chapter 3: Shares - The company issues shares in the form of stocks, with a total of 966,494,707 shares issued, all being ordinary shares [10][21] - The company follows principles of fairness and transparency in share issuance [10] Chapter 4: Shareholders and Shareholder Meetings - Shareholders have rights to dividends, attend meetings, and supervise company operations [16] - The company must hold annual shareholder meetings within six months after the end of the fiscal year [25] Chapter 5: Board of Directors - The board of directors is responsible for the company's management and must act in the best interest of the company and its shareholders [18] - The company has provisions for independent directors and committees within the board [18] Chapter 6: Senior Management - Senior management includes the general manager, deputy general managers, and other key personnel [8] Chapter 7: Financial Accounting System, Profit Distribution, and Auditing - The company must adhere to a financial accounting system and undergo internal audits [8] Chapter 8: Notices and Announcements - The company is required to issue notices and announcements as per legal requirements [8] Chapter 9: Mergers, Divisions, Capital Increases, Reductions, Dissolution, and Liquidation - The company can merge, divide, increase or reduce capital, and dissolve according to legal procedures [8] Chapter 10: Amendments to the Articles - The company can amend its articles of association following the prescribed procedures [8] Chapter 11: Supplementary Provisions - The articles of association serve as a binding document for the company, shareholders, directors, and senior management [8]